Beauty Health (NASDAQ:SKIN) Stock Price Down 3.5% - Here's Why

The Beauty Health Company (NASDAQ:SKIN - Get Free Report) traded down 3.5% during trading on Monday . The company traded as low as $2.19 and last traded at $2.20. 869,179 shares changed hands during mid-day trading, a decline of 10% from the average session volume of 970,992 shares. The stock had previously closed at $2.28.

Analyst Ratings Changes

Separately, Canaccord Genuity Group dropped their target price on shares of Beauty Health from $1.50 to $1.25 and set a "hold" rating on the stock in a research report on Monday, May 5th.

Beauty Health Price Performance

The company has a debt-to-equity ratio of 12.01, a quick ratio of 6.43 and a current ratio of 7.47. The company has a market capitalization of $277.18 million, a PE ratio of -5.37 and a beta of 1.22. The company's 50-day simple moving average is $1.64 and its 200-day simple moving average is $1.49.

Beauty Health (NASDAQ:SKIN - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.05. Beauty Health had a negative net margin of 11.94% and a negative return on equity of 67.91%. The company had revenue of $69.60 million for the quarter, compared to the consensus estimate of $63.88 million. As a group, sell-side analysts anticipate that The Beauty Health Company will post -0.25 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. ProShare Advisors LLC lifted its stake in shares of Beauty Health by 49.0% in the 4th quarter. ProShare Advisors LLC now owns 20,959 shares of the company's stock worth $33,000 after acquiring an additional 6,896 shares during the period. Barclays PLC lifted its stake in shares of Beauty Health by 11.1% in the 4th quarter. Barclays PLC now owns 117,920 shares of the company's stock worth $187,000 after acquiring an additional 11,817 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of Beauty Health in the 4th quarter worth $25,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Beauty Health by 19.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 114,147 shares of the company's stock worth $182,000 after acquiring an additional 18,400 shares during the period. Finally, Bank of Montreal Can lifted its stake in shares of Beauty Health by 32.6% in the 4th quarter. Bank of Montreal Can now owns 113,096 shares of the company's stock worth $180,000 after acquiring an additional 27,791 shares during the period. 93.26% of the stock is owned by hedge funds and other institutional investors.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.